Archive · 18 Sep 2026
Maharashtra FDA Focuses Scrutiny On Infant Nutrition Products
Baby food is made for very young children, so it must meet strict safety and nutrition rules.
Maharashtra's food regulator says it will pay closer attention to these products.
Government data found that some tested samples did not meet the required standards.
Problems can involve germs, harmful substances, ingredients, nutrition levels, labels or expiry dates.
In one case, officials found 3.7 tonnes of expired infant food and ordered it destroyed.
Regulators have also examined claims and ingredients in products made by Nestlé.
Companies have said they followed applicable rules and cooperated with authorities.
A failed sample does not mean every product from that company is unsafe.
The important steps are finding affected batches, removing them and warning families quickly.
Maharashtra FDA Commissioner Tukaram Mundhe identified infant food and child nutrition products as a regulatory focus.
In 2024-25, 45 of 522 tested infant milk substitute and infant food samples were non-conforming.
Authorities have investigated issues involving expired products, contamination allegations, nutritional composition and marketing claims.
FSSAI seized 3.7 metric tonnes of expired infant food from British Life Sciences and ordered its destruction under court directions.
The cases highlight the need for testing, batch tracing, recalls, transparent communication and enforcement.
- Who
- The Maharashtra Food and Drug Administration, FSSAI Commissioner Tukaram Mundhe, manufacturers and infant-food consumers are involved.
- What
- Maharashtra is increasing scrutiny of infant food and child nutrition products amid findings of non-conforming samples and several enforcement cases.
- When
- The focus follows testing data from 2022-23 through 2024-25, recent enforcement against British Life Sciences, and continuing scrutiny of other products.
- Where
- The main regulatory focus is Maharashtra, with cited cases and investigations also involving Bengaluru, Kolkata, India and international examples.
- Why
- Infants are especially vulnerable, and authorities have detected or investigated problems involving safety, expiry, composition, labelling and marketing claims.
Regulatory and Consumer Concerns
Company Responses and Legal Qualifications
Compliance and product safety
Regulatory and Consumer Concerns
Testing and enforcement cases show that infant products can have safety, nutritional, expiry or labelling problems and require scrutiny beyond brand reputation.
Company Responses and Legal Qualifications
Nestlé said it complied with Indian regulations and Codex standards, while the reported findings concern particular products or samples rather than every product from a company.
Added sugar and formulation
Regulatory and Consumer Concerns
Public Eye and the International Baby Food Action Network alleged that Cerelac products sold in India contained added sugar, prompting regulatory attention.
Company Responses and Legal Qualifications
Nestlé said it complied with applicable standards and had reduced added sugars in its infant cereal range by up to 30%, depending on the variant, over the preceding five years.
Legal outcome and broader implications
Regulatory and Consumer Concerns
The Enfamil case illustrates how a consumer complaint and laboratory analysis can trigger legal and regulatory action.
Company Responses and Legal Qualifications
The Calcutta High Court later quashed proceedings against a former managing director on procedural and legal grounds, and the case does not establish that all Enfamil products are unsafe.
- 2024-25 testing
- 522 infant milk substitute and infant food samples were analysed; 45 were non-conforming.
- 2024-25 breakdown
- Five samples were unsafe, 18 were sub-standard and 22 involved labelling defects, misleading claims or other non-conformities.
- Earlier testing
- Seven of 231 samples were non-conforming in 2023-24, while 30 of 389 were non-conforming in 2022-23.
- Expired stock
- FSSAI said 3.7 metric tonnes of expired infant food were seized from British Life Sciences Pvt Ltd in Bengaluru.
- Nestlé scrutiny
- Regulators examined allegations about added sugar, insufficient biotin and claims involving HMOs and easily digestible whey.
- Enfamil case
- A 2015 complaint in Kolkata led to laboratory testing that classified a sample as sub-standard and unsafe; proceedings against a former managing director were quashed in 2026 on procedural and legal grounds.
- Regulatory priorities
- Authorities need to identify batches, stop distribution, remove products, inform consumers and prevent affected stock from re-entering the food chain.